Pharmaceutical Executive-06-18-2009

Pharma is wrestling to understand the emerging markets will be the engine of growth for future sales.

Oscient trims 180 sales, marketing, and corporate jobs in the wake of patent expirations, generic competition.

In an effort to learn as more about epilepsy sufferers, UCB will implement a social network that allows patients to communicate about their disease state and treatments. Think of it as one giant, online clinical trial.

Feds claim results of study comparing car crash deaths and children on ADHD drugs were not paramount to pulling kids off of ADHD treatments.